China Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
China Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the China Cell and Gene Therapy Manufacturing QC Market was valued at USD 304.33 Million in 2024 and is projected to reach USD 777.97 Million by 2028, expanding at a CAGR of 26.5% during the forecast period. This growth is driven by major key sectors including healthcare, pharmaceutical, and biotechnology industries. Crucial industries such as agriculture and energy also contribute to the demand due to their increasing need for advanced gene modification techniques. Technological advancements open up significant opportunities, whereas green production methods align with the current trend towards sustainability. There's potential for export, given China's extensive manufacturing capabilities and increasing standards compliance. As China continues to invest in QC system advancements, it solidifies its position as a significant player in the global Cell and Gene Therapy Manufacturing QC Market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market Highlights
- In 2024, Cell Therapy accounted for the highest share of the Therapy Type market size.
- During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative Therapy Type segment.
- In 2024, China accounted for 13.61% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is expected to lead the global cell and gene therapy manufacturing qc market in terms of market size.
- Within Asia Pacific, China is projected to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
- India is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 58503 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 304.33 Million |
| Market Size In 2028 | USD 777.97 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 26.5% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
China Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
